[go: up one dir, main page]

HK1168751B - 乌利司他醋酸片 - Google Patents

乌利司他醋酸片 Download PDF

Info

Publication number
HK1168751B
HK1168751B HK12102864.5A HK12102864A HK1168751B HK 1168751 B HK1168751 B HK 1168751B HK 12102864 A HK12102864 A HK 12102864A HK 1168751 B HK1168751 B HK 1168751B
Authority
HK
Hong Kong
Prior art keywords
tablet
ulipristal acetate
amount
povidone
diluent
Prior art date
Application number
HK12102864.5A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1168751A (zh
Inventor
Erin Gainer
Hélène GUILLARD
Denis Gicquel
Marianne Henrion
Céline GNAKAMENE
Original Assignee
Laboratoire Hra Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Hra Pharma filed Critical Laboratoire Hra Pharma
Publication of HK1168751A publication Critical patent/HK1168751A/zh
Publication of HK1168751B publication Critical patent/HK1168751B/zh

Links

HK12102864.5A 2008-12-08 2009-12-08 乌利司他醋酸片 HK1168751B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US329865 2008-12-08

Publications (2)

Publication Number Publication Date
HK1168751A HK1168751A (zh) 2013-01-11
HK1168751B true HK1168751B (zh) 2017-10-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP2365800B1 (en) Ulipristal acetate tablets
US7985421B2 (en) Sustained release formulations of guaifenesin and additional drug ingredients
US20190209551A1 (en) Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer
HK1168751B (zh) 乌利司他醋酸片
EP4598512A1 (en) Immediate release oral pharmaceutical composition comprising linagliptin
TW202432128A (zh) （Ｒ）－１－（１－丙烯醯基哌啶－３－基）－４－胺基－３－（４－苯氧基苯基）－１Ｈ－咪唑並［４，５－ｃ］吡啶－２（３Ｈ）－酮之藥品調配物
WO2025144122A1 (en) Pharmaceutical composition comprising dapagliflozin base in amorphous form
KR20070023743A (ko) 메만틴의 조절된 방출 제제